Lipotes vexillifer (Yangtze River dolphin): 103073819
Help
Entry
103073819 CDS
T03090
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
lve
Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01524
Platinum drug resistance
lve04010
MAPK signaling pathway
lve04115
p53 signaling pathway
lve04148
Efferocytosis
lve04210
Apoptosis
lve04215
Apoptosis - multiple species
lve04623
Cytosolic DNA-sensing pathway
lve04650
Natural killer cell mediated cytotoxicity
lve04657
IL-17 signaling pathway
lve04668
TNF signaling pathway
lve04726
Serotonergic synapse
lve04932
Non-alcoholic fatty liver disease
lve04933
AGE-RAGE signaling pathway in diabetic complications
lve04936
Alcoholic liver disease
lve05010
Alzheimer disease
lve05012
Parkinson disease
lve05014
Amyotrophic lateral sclerosis
lve05016
Huntington disease
lve05020
Prion disease
lve05022
Pathways of neurodegeneration - multiple diseases
lve05132
Salmonella infection
lve05133
Pertussis
lve05134
Legionellosis
lve05145
Toxoplasmosis
lve05146
Amoebiasis
lve05152
Tuberculosis
lve05160
Hepatitis C
lve05161
Hepatitis B
lve05162
Measles
lve05163
Human cytomegalovirus infection
lve05164
Influenza A
lve05165
Human papillomavirus infection
lve05167
Kaposi sarcoma-associated herpesvirus infection
lve05168
Herpes simplex virus 1 infection
lve05169
Epstein-Barr virus infection
lve05170
Human immunodeficiency virus 1 infection
lve05200
Pathways in cancer
lve05203
Viral carcinogenesis
lve05205
Proteoglycans in cancer
lve05206
MicroRNAs in cancer
lve05210
Colorectal cancer
lve05222
Small cell lung cancer
lve05416
Viral myocarditis
lve05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
lve00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103073819 (CASP3)
04668 TNF signaling pathway
103073819 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
103073819 (CASP3)
09143 Cell growth and death
04210 Apoptosis
103073819 (CASP3)
04215 Apoptosis - multiple species
103073819 (CASP3)
04115 p53 signaling pathway
103073819 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
103073819 (CASP3)
04650 Natural killer cell mediated cytotoxicity
103073819 (CASP3)
04657 IL-17 signaling pathway
103073819 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
103073819 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103073819 (CASP3)
05206 MicroRNAs in cancer
103073819 (CASP3)
05205 Proteoglycans in cancer
103073819 (CASP3)
05203 Viral carcinogenesis
103073819 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
103073819 (CASP3)
05222 Small cell lung cancer
103073819 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
103073819 (CASP3)
05161 Hepatitis B
103073819 (CASP3)
05160 Hepatitis C
103073819 (CASP3)
05164 Influenza A
103073819 (CASP3)
05162 Measles
103073819 (CASP3)
05168 Herpes simplex virus 1 infection
103073819 (CASP3)
05163 Human cytomegalovirus infection
103073819 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
103073819 (CASP3)
05169 Epstein-Barr virus infection
103073819 (CASP3)
05165 Human papillomavirus infection
103073819 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
103073819 (CASP3)
05133 Pertussis
103073819 (CASP3)
05134 Legionellosis
103073819 (CASP3)
05152 Tuberculosis
103073819 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
103073819 (CASP3)
05145 Toxoplasmosis
103073819 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
103073819 (CASP3)
05012 Parkinson disease
103073819 (CASP3)
05014 Amyotrophic lateral sclerosis
103073819 (CASP3)
05016 Huntington disease
103073819 (CASP3)
05020 Prion disease
103073819 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
103073819 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103073819 (CASP3)
05416 Viral myocarditis
103073819 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
103073819 (CASP3)
04932 Non-alcoholic fatty liver disease
103073819 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
103073819 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
103073819 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
lve01002
]
103073819 (CASP3)
Enzymes [BR:
lve01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
103073819 (CASP3)
Peptidases and inhibitors [BR:
lve01002
]
Cysteine peptidases
Family C14: caspase family
103073819 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
103073819
NCBI-ProteinID:
XP_007466580
UniProt:
A0A340Y521
LinkDB
All DBs
Position
Unknown
AA seq
275 aa
AA seq
DB search
MENNENSVDSKSIKSSETKILHGSKSMDSGISLDYSYKMDYPEMGLCIIINNKNFHESTG
MACRSGTDVDAANLWETFTNLKYEVRNKNDLTCEEILELMYSVSKEDHSKRSSFICVLLS
HGEEGKIFGTNGPVDLKKLTGFFRGDCCISLTGKPKLFVIQACRGTELDCGIETDSGVED
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYAHKLELMHILTRVN
RKVAIEFESFSNDSTFHAKKQIPCIVSMLTKELYF
NT seq
828 nt
NT seq
+upstream
nt +downstream
nt
atggagaacaatgaaaattcagtggattcaaaatccattaaatcttcagagacaaagatc
ttacatggaagcaaatcaatggactctggaatatccttggactatagttacaaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcatgaaagtactggg
atggcgtgtcggtctggtacagacgtagatgcagcaaacctctgggaaaccttcacgaac
ttgaaatatgaagttaggaataaaaatgatcttacatgtgaagaaattttggaattaatg
tacagtgtttctaaagaagatcatagcaaaaggagcagttttatttgcgtgcttctaagc
catggcgaggaaggaaaaatttttggaacaaatggacctgtcgatctgaaaaaattaaca
ggcttcttcagaggggattgttgtataagtctaactggaaaacctaaactcttcgttatt
caggcttgccgaggcacagaactggactgtggtattgagacagacagtggagttgaggat
gacatggcctgtcagaaaataccggttgaggcggacttcttgtatgcatattctacagca
cctggttactattcctggcgaaattcaaaggacggatcctggttcatccagtcactttgt
gcaatgctgaaacagtatgctcacaagcttgagcttatgcacattctcactcgggttaac
cgaaaggtagcaatagaattcgagtccttttccaatgattctacttttcatgcaaagaaa
cagattccttgtattgtgtctatgctcacaaaagaactgtatttttaa
DBGET
integrated database retrieval system
